References in periodicals archive ?
sativa in yeast-induced pyrexia method suggests that it may not inhibit the synthesis of interleukins.
7) The definition of fever in the critically ill is identical to that of Petersdorf and Beeson, and new-onset pyrexia of [greater than or equal to] 38.
The subcutaneous injection of brewer's yeast evoked pyrexia by ultimately increasing synthesis of prostaglandin and is considered as a valuable in-vivo screening test for the assessment of antipyretic potential (Muhammad et al.
Group A comprised 235 patients diagnosed by clinicians of having pyrexia, and group B included stool samples of 206 patients presenting with gastroenteritis.
Infection was defined as cases of confirmed diagnosis of infection and also those treated with antibiotics for any reason, including presumptive infection based on the presence of prolonged bleeding, abdominal pain, offensive discharge and/or pyrexia.
Exposure to isolated fever was defined as maternal intrapartum fever of 38[degrees] C or greater, or ICD-9 diagnosis of maternal intrapartum pyrexia without chorioamnionitis.
In Xeloda monotherapy for metastatic colorectal cancer, the most common adverse events were anemia (80%), diarrhea (55%), hand-foot syndrome (54%), hyperbilirubinemia (48%), nausea (43%), fatigue/weakness (42%), abdominal pain (35%), dermatitis (27%), vomiting (27%), appetite decreased (26%), stomatitis (25%), pyrexia (18%), edema (15%), constipation (14%), dyspnea (14%), neutropenia (13%), pain (12%), back pain (10%), and headache (10%).
3 mg/m(2)/dose in phase II studies, the most commonly reported adverse events were asthenic conditions (65 percent), nausea (64 percent), diarrhea (51 percent), decreased appetite including anorexia (43 percent), constipation (43 percent), thrombocytopenia (43 percent), peripheral neuropathy (37 percent), pyrexia (36 percent), vomiting (36 percent), and anemia (32 percent).
On examination he was confused with a pyrexia of 38[degrees]C, a pulse of 90/min and a mitral regurgitation murmur.
The most common adverse events observed, were headache (20%), mostly mild or moderate, pyrexia (13%), chills (10%), and fatigue (8%).
In the field study, Zimeta administered at 30 mg/kg intravenously was effective for the control of pyrexia six hours following treatment administration, the company said.